AYUMI Pharmaceutical Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 363

Employees

  • Latest Deal Type
  • Buyout/​LBO
  • (Cancelled)

  • Financing Rounds
  • 4

AYUMI Pharmaceutical General Information

Description

Manufacturer of specialty pharmaceuticals based in Tokyo, Japan. The company offers a portfolio of drug products addressing anti-rheumatism and orthopedic pain management through an expert team of doctors, enabling patients to get a cure for their disease and stay healthy.

Contact Information

Formerly Known As
Santen Pharmaceutical (Rheumatism business)
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Kabukiza Tower 19 Floor
  • 4-12-15 Ginza, Chuo-ku
  • Tokyo, 104-0061
  • Japan
+81
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Kabukiza Tower 19 Floor
  • 4-12-15 Ginza, Chuo-ku
  • Tokyo, 104-0061
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AYUMI Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AYUMI Pharmaceutical‘s full profile, request access.

Request a free trial

AYUMI Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of specialty pharmaceuticals based in Tokyo, Japan. The company offers a portfolio of drug products address
Pharmaceuticals
Tokyo, Japan
363 As of 2021

Indianapolis, IN
 

Rahway, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AYUMI Pharmaceutical Competitors (16)

One of AYUMI Pharmaceutical’s 16 competitors is Eli Lilly and Company, a Corporation company based in Indianapolis, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eli Lilly and Company Corporation Indianapolis, IN
Merck & Co. Corporation Rahway, NJ
Brii Biosciences Formerly VC-backed Beijing, China
Catalyst Pharmaceuticals Corporation Coral Gables, FL
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 16 competitors. Get the full list »

AYUMI Pharmaceutical Patents

AYUMI Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230255907-A1 Tablet and method for manufacturing same Pending 03-Jul-2020
JP-7360460-B2 Orally disintegrating tablet and its manufacturing method Active 07-Jun-2019
EP-3981432-A4 Therapeutic agent for wolfram syndrome Active 27-Mar-2019
EP-3981432-A1 Therapeutic agent for wolfram syndrome Active 27-Mar-2019
JP-7494163-B2 Treatment for wolfram syndrome Active 27-Mar-2019 A61P3/10
To view AYUMI Pharmaceutical’s complete patent history, request access »

AYUMI Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AYUMI Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AYUMI Pharmaceutical‘s full profile, request access.

Request a free trial

AYUMI Pharmaceutical FAQs

  • When was AYUMI Pharmaceutical founded?

    AYUMI Pharmaceutical was founded in 2015.

  • Where is AYUMI Pharmaceutical headquartered?

    AYUMI Pharmaceutical is headquartered in Tokyo, Japan.

  • What is the size of AYUMI Pharmaceutical?

    AYUMI Pharmaceutical has 363 total employees.

  • What industry is AYUMI Pharmaceutical in?

    AYUMI Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is AYUMI Pharmaceutical a private or public company?

    AYUMI Pharmaceutical is a Private company.

  • What is the current valuation of AYUMI Pharmaceutical?

    The current valuation of AYUMI Pharmaceutical is .

  • What is AYUMI Pharmaceutical’s current revenue?

    The current revenue for AYUMI Pharmaceutical is .

  • Who are AYUMI Pharmaceutical’s investors?

    Hisamitsu Pharmaceutical, Toho Holdings, and Blackstone have invested in AYUMI Pharmaceutical.

  • Who are AYUMI Pharmaceutical’s competitors?

    Eli Lilly and Company, Merck & Co., Brii Biosciences, Catalyst Pharmaceuticals, and Genentech are some of the 16 competitors of AYUMI Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »